WYETH for WYETH

Trade (domestic/foreign) TRD

Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement Importation of FDA-approved pharmaceuticals

Contacted: SENATE; Natl Security Agency (NSA); Treasury, Dept of; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of the Vice President of the United States; Natl Security Council (NSC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; White House Office; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Justice, Dept of (DOJ)

Taxation/Internal Revenue Code TAX

Taxation of International Operations of U.S. corporations generally; Homeland investment legislation; R&D tax credit; H.R. 1424 and H.R. 7060;

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); White House Office; Natl Security Agency (NSA); Justice, Dept of (DOJ); State, Dept of (DOS); Natl Security Council (NSC); Food & Drug Administration (FDA); Office of the Vice President of the United States; Treasury, Dept of

Bills named: H.R. 7060 (110th), H.R. 1424 (110th)

Copyright/Patent/Trademark CPT

Monitor U.S. trade policies relating to intellectual property protection under the WTO/TRIPS agreement H.R. 1908 Patent Reform Act of 2007 S. 1145 Patent Reform Act of 2007

Contacted: Justice, Dept of (DOJ); Natl Security Agency (NSA); State, Dept of (DOS); U.S. Trade Representative (USTR); SENATE; Office of the Vice President of the United States; Treasury, Dept of; HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Natl Security Council (NSC)

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Health Issues HCR

Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Alzheimer's care Comparative effectiveness - S.3408 - Comparative Effectiveness Research Act of 2008 S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption S.3613, H.R. 7114 - Independence at Home Act S.3409-Drug and Device Accountability Act of 2008 Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic Illness International public health issues International vaccine issues

Contacted: Office of the Vice President of the United States; U.S. Trade Representative (USTR); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Natl Security Agency (NSA); Executive Office of the President (EOP); White House Office; Justice, Dept of (DOJ); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Treasury, Dept of

Bills named: S. 1695 (110th), H.Con.Res. 342 (110th), S. 2029 (110th), S. 623 (110th), H.R. 7114 (110th), H.R. 5629 (110th), S. 1505 (110th), S. 3409 (110th), S. 3613 (110th), S. 3408 (110th), S. 334 (110th), H.R. 1038 (110th), H.R. 3610 (110th), H.R. 1812 (110th), H.R. 1956 (110th)

Medicare/Medicaid MMM

Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 - Medicare Prescription Drug Price Negotiation Act H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S.1893/H.R. 976 - Children's Health Insurance Progam Reauthorization Act of 2007 S. 2499 - Medicare, Medicaid and SCHIP Extension Act of 2007 Chronic care out of pocket costs S. 2029 - Physician Payments Sunshine Act of 2007 HR 5605 - Physician Payments Sunshine Act of 2007 HR 2185 - Enhanced Healthcare Value for All Act Medicare Prescription Drug Benefit Medicaid drug rebate Medicare Physician Reimbursement package Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference H.R. 6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008 S.3118 - Preserving Access to Medicare Act of 2008 S.3613, H.R. 7114 - Independence at Home Act

Contacted: U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Natl Security Council (NSC); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; State, Dept of (DOS); White House Office; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Natl Security Agency (NSA); Treasury, Dept of

Bills named: S. 2029 (110th), H.R. 6331 (110th), S. 2499 (110th), H.R. 4 (110th), S. 1893 (110th), H.R. 5605 (110th), H.R. 976 (110th), H.R. 7114 (110th), S. 3101 (110th), H.R. 2185 (110th), S. 3613 (110th), S. 1932 (110th), H.R. 3162 (110th), S. 3118 (110th)

Consumer Issues/Safety/Products CSP

FDA reform proposals; Pseudoephedrine H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act S. 2274 Dextromethorphan Abuse Reduction Act Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Natl Security Agency (NSA); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Treasury, Dept of; Justice, Dept of (DOJ); Office of the Vice President of the United States; White House Office; State, Dept of (DOS)

Bills named: H.R. 970 (110th), S. 1378 (110th), S. 2274 (110th)

Pharmacy PHA

H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics S.1695 - Biologics Price Competition and Innovation Act of 2007 S.1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act" H.R. 3610 - Food and Drug Import Safety Act of 2007 S.3409 - Drug and Device Accountability Act of 2008 Biosimilars Drug Safety Prescription Drug Importation Import Safety Compoundin

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Natl Security Agency (NSA); Office of the Vice President of the United States; Executive Office of the President (EOP); Justice, Dept of (DOJ); State, Dept of (DOS); Natl Security Council (NSC); White House Office

Bills named: S. 1505 (110th), S. 623 (110th), H.R. 5629 (110th), H.R. 1956 (110th), S. 1695 (110th), H.R. 3610 (110th), S. 3409 (110th), H.R. 1038 (110th)